INT158321

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.75
First Reported 2004
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 11
Total Number 11
Disease Relevance 7.07
Pain Relevance 1.40

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Mention Frequency
blood 1


Pain Term Frequency Confidence Heat
cva 22 100.00 Very High Very High Very High
metalloproteinase 24 98.20 Very High Very High Very High
noradrenaline 26 93.20 High High
Dopamine 26 92.60 High High
Acupuncture 61 92.44 High High
Osteoarthritis 66 91.28 High High
COX2 3 89.88 High High
Hyperalgesia 3 78.28 Quite High
Pain 11 75.64 Quite High
Analgesic 1 71.08 Quite High
Disease Term Frequency Confidence Heat
Cv General 3 Under Development 20 100.00 Very High Very High Very High
Stress 246 99.36 Very High Very High Very High
Polycystic Ovary Syndrome 89 96.96 Very High Very High Very High
Osteoarthritis 67 91.28 High High
Cv General 2 Under Development 70 85.36 High High
Disease Progression 1 84.80 Quite High
Low Tension Glaucoma 37 81.76 Quite High
Hyperalgesia 4 78.28 Quite High
Nociception 2 77.60 Quite High
Pain 2 75.64 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Should the infusion rate be titrated against MAP or AVP levels?
Gene_expression (levels) of MAP
1) Confidence 0.75 Published 2005 Journal Crit Care Section Body Doc Link PMC1175907 Disease Relevance 0.59 Pain Relevance 0.29
CONCLUSIONS AND CLINICAL RELEVANCE: When using an oscillometric blood pressure monitor on anesthetized boid snakes, veterinarians can potentially monitor changes in blood pressure, although the displayed readings may underestimate DAP and MAP and overestimate SAP.
Gene_expression (underestimate) of MAP in blood
2) Confidence 0.65 Published 2009 Journal J. Am. Vet. Med. Assoc. Section Body Doc Link 19250041 Disease Relevance 0 Pain Relevance 0
Changes in ICP, MAP, CPP
Gene_expression (Changes) of MAP associated with cva
3) Confidence 0.65 Published 2005 Journal Journal of Korean Medical Science Section Body Doc Link PMC2779288 Disease Relevance 0.54 Pain Relevance 0.20
= interleukin 1 beta; JNK = c-jun N-terminal kinase; MAP = mitogen-activated protein; MEK1/2 = mitogen-activated protein kinase kinase; MMP = matrix metalloproteinase; NF-?
Gene_expression (/) of MAP associated with metalloproteinase
4) Confidence 0.65 Published 2007 Journal Arthritis Res Ther Section Body Doc Link PMC2246240 Disease Relevance 1.06 Pain Relevance 0.75
with MAPs or dysregulate MAP expression.
Gene_expression (expression) of MAP
5) Confidence 0.58 Published 2008 Journal PPAR Research Section Body Doc Link PMC2396401 Disease Relevance 0.06 Pain Relevance 0
SBP, DBP and MAP were significantly higher in the novelty stress and stress periods (day 1) compared to control 1 and 2 (day 2), whereas HR tended to be higher in the novelty stress and stress periods compared to control 1 and 2 (P = 0.055).
Gene_expression (higher) of MAP associated with stress
6) Confidence 0.58 Published 2005 Journal BMC Musculoskelet Disord Section Body Doc Link PMC1185546 Disease Relevance 1.40 Pain Relevance 0
SBP, DBP, MAP and HR are presented in table 1.
Gene_expression (presented) of MAP
7) Confidence 0.58 Published 2005 Journal BMC Musculoskelet Disord Section Body Doc Link PMC1185546 Disease Relevance 1.38 Pain Relevance 0
When expressed as percent change from the resting period, the SBP, DBP, MAP and HR were significantly elevated in the novelty stress and stress periods compared to the control period.
Gene_expression (expressed) of MAP associated with stress
8) Confidence 0.58 Published 2005 Journal BMC Musculoskelet Disord Section Body Doc Link PMC1185546 Disease Relevance 1.61 Pain Relevance 0
For comparison with the responses of OBF, responses of MAP were also expressed as percentage of the pre-stimulus value.


Gene_expression (expressed) of MAP
9) Confidence 0.58 Published 2004 Journal Reprod Biol Endocrinol Section Body Doc Link PMC411056 Disease Relevance 0.10 Pain Relevance 0.16
There was significant increase in post-treatment levels of SBP, MAP, SVRI, VO2I, DO2I, and HVOS in both the groups [Table 4].
Gene_expression (levels) of MAP
10) Confidence 0.58 Published 2010 Journal Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine Section Body Doc Link PMC2888327 Disease Relevance 0.07 Pain Relevance 0
However, the mean nocturnal SBP, DBP, MAP, and fluctuation of the SBP, DBP, and MAP were all significantly different among the groups (p<0.05).
Gene_expression (fluctuation) of MAP
11) Confidence 0.29 Published 2009 Journal Korean Journal of Ophthalmology : KJO Section Body Doc Link PMC2655738 Disease Relevance 0.27 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox